£78.95

It has never been this cheap. We have no record of a lower price.

£79 today · cheaper than every other day in the last 3 months

Adis Ketamine for Treatment-Resistant Depression: The First Decade of Progress

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 54 days · 54 data points (no recent data)

Historical
Generating forecast…
£80.67 £78.78 £79.19 £79.60 £80.02 £80.43 £80.84 16 August 2026 29 August 2026 11 September 2026 24 September 2026 08 October 2026
View at Amazon ↗

Price data last checked 37 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 54 days • 2 price levels

Days at Price
Current Price
44 days · current 10 days 0 11 22 33 44 £79 £81 Days at Price

Price Analysis

Most common price: £79 (44 days, 81.5%)

Price range: £79 - £81

Price levels: 2 different prices over 54 days

Description

This book brings together an international group of clinicians and researchers from a broad swath of inter-related disciplines to offer the most up-to-date information about clinical and preclinical research into ketamine and second-generation “ketamine-like” fast-acting antidepressants. Currently available antidepressant medications act through monoaminergic systems, are ineffective for many individuals suffering from depression, and are associated with a delayed onset of peak efficacy of several months. The unexpected emergence of ketamine, an anesthetic N-methyl-D-aspartate (NMDA) receptor antagonist, as a rapid-acting antidepressant has reinvigorated CNS drug discovery research and catalyzed investigation in patient populations historically ignored in antidepressant drug development programs, particularly treatment-resistant patients and those with suicidality. Recent industry and academic research efforts have coalesced to explore NMDA receptor and glutamatergic moleculartargets that lack ketamine’s psychotomimetic side effects and abuse liability but retain its rapid onset of efficacy. However, many fundamental questions remain regarding the neurobiological mechanisms underlying ketamine’s rapid antidepressant effects and the puzzling persistence of benefits observed in some patients following a single dose. This book examines how insights from these studies are forging new conceptual models of the neurobiology of stress-related affective, anxiety, and addictive disorders and the nature of treatment resistance. It also discusses how ketamine’s rapid antidepressant effects provide a scientific platform to facilitate innovation in clinical trial designs pertaining to patient selection, choice of control group, outcome measures, and dose-optimization. This book brings together data and insights from this rapidly expanding and extraordinarily promising field of study. Readers will be able to extract integrated themes and useful insights from the material contained in these diverse chapters and appreciate the paradigm-shifting contributions of ketamine to modern psychiatry and clinical neuroscience research.

Product Specifications

Brand
Adis
Format
hardcover
Domain
Amazon UK
Release Date
15 December 2016
Listed Since
15 June 2016

Barcode

No barcode data available

Similar Products You Might Like

Ketamine for Treatment-Resistant Depression: The First Decade of Progress
98% match

Ketamine for Treatment-Resistant Depression: The First Decade of Progress

Adis

£65.61 23 Sep 2026
Neuropsychopharmacology of the Trace Amines: Experimental and Clinical Aspects (Experimental and Clinical Neuroscience)
96% match

Neuropsychopharmacology of the Trace Amines: Experimental and Clinical Aspects (Experimental and Clinical Neuroscience)

Humana

£165.06 03 Sep 2026
Neuropsychopharmacology of the Trace Amines: Experimental and Clinical Aspects (Experimental and Clinical Neuroscience)
96% match

Neuropsychopharmacology of the Trace Amines: Experimental and Clinical Aspects (Experimental and Clinical Neuroscience)

Humana

£141.86 02 Oct 2026
Brain Function and Psychotropic Drugs (Oxford Medical Publications)
96% match

Brain Function and Psychotropic Drugs (Oxford Medical Publications)

Oxford University Press

£59.00 10 Sep 2026
Neurobiology of Depression: Road to Novel Therapeutics
96% match

Neurobiology of Depression: Road to Novel Therapeutics

Elsevier

£103.89 05 Sep 2026
Pediatric Psychopharmacology: Principles and Practice
96% match

Pediatric Psychopharmacology: Principles and Practice

Oxford University Press

£95.00 11 Sep 2026
In Vivo Neuropharmacology and Neurophysiology: 121 (Neuromethods, 121)
96% match

In Vivo Neuropharmacology and Neurophysiology: 121 (Neuromethods, 121)

Humana

£81.06 26 Sep 2026
Major Depressive Disorder: Risk Factors, Characteristics & Treatment Options (Psychiatry - Theory, Applications and Treatments)
96% match

Major Depressive Disorder: Risk Factors, Characteristics & Treatment Options (Psychiatry - Theory, Applications and Treatments)

Price unavailable
In Vivo Neuropharmacology and Neurophysiology: 121 (Neuromethods, 121)
96% match

In Vivo Neuropharmacology and Neurophysiology: 121 (Neuromethods, 121)

Humana

£104.34 17 Sep 2026
Psychopharmacology: 13 (Neuromethods, 13)
96% match

Psychopharmacology: 13 (Neuromethods, 13)

Humana

£166.29 23 Sep 2026
Molecular Psychiatry
96% match

Molecular Psychiatry

MDPI AG

£61.89 13 Sep 2026
5-HT2C Receptors in the Pathophysiology of CNS Disease: 22 (The Receptors, 22)
96% match

5-HT2C Receptors in the Pathophysiology of CNS Disease: 22 (The Receptors, 22)

Humana

£141.67 24 Sep 2026
Springer Neuroscience for Psychologists and Mental Health Pro
96% match

Springer Neuroscience for Psychologists and Mental Health Pro

Springer Publishing Company

£57.89 17 Oct 2026
Drug Development in Psychiatry: 30 (Advances in Neurobiology, 30)
96% match

Drug Development in Psychiatry: 30 (Advances in Neurobiology, 30)

Springer

£141.78 02 Oct 2026
Electrophysiology and Psychophysiology in Psychiatry and Psychopharmacology: 21 (Current Topics in Behavioral Neurosciences, 21)
96% match

Electrophysiology and Psychophysiology in Psychiatry and Psychopharmacology: 21 (Current Topics in Behavioral Neurosciences, 21)

Springer

£108.92 11 Nov 2026
A PRACTICAL GUIDE TO TRANSCRANIAL MAGNETIC STIMULATION NEUROPHYSIOLOGY
96% match

A PRACTICAL GUIDE TO TRANSCRANIAL MAGNETIC STIMULATION NEUROPHYSIOLOGY

Oxford University Press

£52.00 06 Nov 2026
Elsevier Interventional Psychiatry: Road to Novel Therapeutics
96% match

Elsevier Interventional Psychiatry: Road to Novel Therapeutics

Elsevier

£129.19 13 Nov 2026
Massachusetts General Hospital Psychopharmacology and Neurotherapeutics
96% match

Massachusetts General Hospital Psychopharmacology and Neurotherapeutics

Elsevier

£33.17 06 Nov 2026
New Rapid-acting Antidepressants (Contemporary Clinical Neuroscience)
96% match

New Rapid-acting Antidepressants (Contemporary Clinical Neuroscience)

Springer

£134.41 07 Nov 2026
Lippincott Kaplan and Sadock's Psychiatric Drug Handbook
96% match

Lippincott Kaplan and Sadock's Psychiatric Drug Handbook

Lippincott Williams & Wilkins

£66.86 07 Nov 2026
Facilitating Resilience after PTSD: A Translational Approach (Psychiatry - Theory, Applications and Treatments)
96% match

Facilitating Resilience after PTSD: A Translational Approach (Psychiatry - Theory, Applications and Treatments)

£236.56 04 Nov 2026
Greenshaw: Experimental ∗psychopharmacology∗ – Concepts & Methods (Contemporary Neuroscience)
96% match

Greenshaw: Experimental ∗psychopharmacology∗ – Concepts & Methods (Contemporary Neuroscience)

Humana

£76.35 11 Sep 2026
The Nature of Depression: An Updated Review
96% match

The Nature of Depression: An Updated Review

Academic Press

£90.47 13 Oct 2026
Clinical Pharmacology in Psychiatry - Psychotropic Drug Development
96% match

Clinical Pharmacology in Psychiatry - Psychotropic Drug Development

Springer

£109.13 06 Oct 2026